These transgenic mice, sometimes referred to as hm2α-SYN-39, contain a mutated human alpha synuclein protein found in human Parkinson Disease patients and under the control of the rat tyrosine hydroxylase promoter. Expression is detected in cell bodies, axons, and terminals of the nigrostriatal system.
Eric Richfield, Rutger's University (EOHSI/UMDNJ)
These hm2α-SYN-39 mice express a doubly-mutant form of human alpha-synuclein (hα-SYN) containing the A30P and A53T human mutations associated with autosomal dominant Parkinson's disease, under the control of the rat tyrosine hydroxylase promoter. Expression of hα-SYN is detected in cell bodies, axons, and terminals of the nigrostriatal system (mRNA expression in midbrain, eye, and adrenal gland, with high levels of protein expression in the cell bodies of dopaminergic neurons in the midbrain and striatum). Hemizygous mice exhibit several Parkinson's disease-related characteristics including increased density of the dopamine transporter, impairments of the ubiquitin-proteasome system, and age-related progressive loss of locomotor activity and substantia nigra pars compacta dopaminergic neurons. The Parkinson's disease-related phenotype of hm2α-SYN-39 mice is more severe than that of the control strain (hwα-SYN-5, see Stock No. 008245). These hm2α-SYN-39 transgenic mice may be useful for studying Parkinson's disease, Lewy bodies, neurodegeneration, and synaptic plasticity.
A 469 bp human alpha-synuclein cDNA was modified by site-directed mutagenesis to contain the A30P and A53T Parkinson's disease-linked mutations. This mutant cDNA was and then placed downstream of a 9 kb rat tyrosine hydroxylase promoter (and splice donor/intron/splice acceptor) and upstream of a polyA signal. The resulting transgene was injected into C57BL/6 oocytes. Mice from founder line 39 (hm2α-SYN-39) were found to have the highest levels of transgene mRNA expression in midbrain. These hm2α-SYN-39 mice were maintained by breeding transgenic mice with wildtype or C57BL/6J for many generations prior sending to The Jackson Laboratory Repository. Upon arrival, mice were bred to C57BL/6J (Stock No. 000664) for at least one generation to establish the colony.
|Expressed Gene||SNCA, synuclein alpha, human|
|Site of Expression|
|Allele Name||transgene insertion 39, Eric K Richfield|
|Allele Type||Transgenic (Inserted expressed sequence, Humanized sequence)|
|Allele Synonym(s)||Tg(Th-SNCA*A30P*A53T)39Eric; transgene insertion 39, Eric K Richfield|
|Gene Symbol and Name||Tg(Th-SNCA*A30P*A53T)39Eric, transgene insertion 39, Eric K Richfield|
|Gene Synonym(s)||Tg(Th-SNCA*A30P*A53T)39Fed; Tg(Thy1-SNCA*A30P,A53T)39Fed; THsynDM; Tg(Thy1-SNCA*A30P*A53T)39Fed; Tg(Thy1-SNCA*A30P,A53T)39Fed; hm2alpha-SYN-39; Tg(Th-SNCA*A30P*A53T)39Fed; transgene insertion 39, Howard J Federoff|
|Promoter||Th, tyrosine hydroxylase, rat|
|Expressed Gene||SNCA, synuclein alpha, human|
|Strain of Origin||C57BL/6|
|General Note||Young transgenic mice demonstrated significantly increased locomotor activity and a shorter time to right compared to both nontransgenic littermates and Tg(SNCA)5Fed transgenic mice, which express the wild-type human gene under control of a 9 kb rat Thy1 promoter. Locomotor responses to amphetamine were impaired in young transgenic mice. The abnormal axons visualized in the median forebrain bundle of transgenic mice were more dilated and beaded in appearance compared to those seen in nontransgenic littermate controls. The terminals in the nucleus accumbens of transgenic mice also appeared abnormal with the smaller caliber processes and terminals often dilated or enlarged compared to those seen in nontransgenic littermate controls. Neither compact round cytoplasmic inclusions nor intranuclear inclusions were identified in transgenic mice at 4 months of age. J). Axons in transgenic mice that stained for Thy1 were beaded and dilated in appearance and displayed increased discontinuities.|
|Molecular Note||The transgene contains a 9 kb rat tyrosine hydroxylase promoter, a splice donor/intron/splice acceptor, a poly(A) site from the human growth hormone gene, and a mutated human alpha synuclein cDNA encoding a protein that carries two amino acid substitutions, Ala53Thr and Ala30Pro, which are found in human Parkinson Disease patients. RT-PCR detected transgene expression in midbrain, eye, and adrenal gland. Real time quantitative RT-PCR as well as in situ hybridization histochemistry detected high levels of transgene expression in the midbrain. Catecholaminergic nuclei in the brain of transgenic mice expressed both human mRNA and human protein. These mice express high levels of the human protein in the cell bodies of dopaminergic neurons in the midbrain and its main projection region, the striatum, dopaminergic dendrites, and nigrostriatal axons and terminals.|
|Mutations Made By|| |
Eric Richfield, Rutger's University (EOHSI/UMDNJ)
When maintaining a live colony, hemizygotes are bred to wildtype siblings or to inbred C57BL/6J mice.
When using the hm2α-SYN-39 mouse strain in a publication, please cite the originating article(s) and include JAX stock #008239 in your Materials and Methods section.
|Hemizygous or non carrier for Tg(Th-SNCA*A30P*A53T)39Eric|
We will fulfill your order by providing at least two carriers for each strain ordered. The total number, sex, and genotypes provided will vary, although typically 8 or more animals are provided. Please check genotypes which will be recovered. While the genotypes of all animals produced will be communicated to you prior to scheduling shipment, the genotypes of animals provided may not reflect the mating scheme and genotypes described in the strain description. Animals are typically ready to ship in 11-14 weeks. If a second recovery is required to produce the minimum number of animals, then delivery time would increase to approximately 25 weeks. If we fail to produce animals of the correct genotype, you will not be charged. We cannot guarantee the reproductive success of mice shipped to your facility. If the mice are lost after the first three days (post-arrival) or do not produce progeny at your facility, a new order and fee will be necessary.
Cryorecovery to establish a Dedicated Supply for greater quantities of mice. Mice recovered can be used to establish a dedicated colony to contractually supply you mice according to your requirements. Price by quotation.
"MICE" means mouse strains, their progeny derived by inbreeding or crossbreeding, unmodified derivatives from mouse strains or their progeny supplied by The Jackson Laboratory ("JACKSON"). "PRODUCT(S)" means biological materials supplied by JACKSON, and their derivatives. "SERVICES" means projects conducted by JACKSON for other parties that may include but are not limited to the use of MICE or PRODUCTS. "RECIPIENT" means each recipient of MICE, PRODUCTS, or SERVICES provided by JACKSON including each institution, its employees and other researchers under its control. MICE or PRODUCTS shall not be: (i) used for any purpose other than internal research, (ii) sold or otherwise provided to any third party for any use, or (iii) provided to any agent or other third party to provide breeding or other services. Acceptance of MICE, PRODUCTS or SERVICES from JACKSON shall be deemed as agreement by RECIPIENT to these conditions, and departure from these conditions requires JACKSON’s prior written authorization.
MICE, PRODUCTS AND SERVICES ARE PROVIDED "AS IS". JACKSON EXTENDS NO WARRANTIES OF ANY KIND, EITHER EXPRESS, IMPLIED, OR STATUTORY, WITH RESPECT TO MICE, PRODUCTS OR SERVICES, INCLUDING ANY IMPLIED WARRANTY OF MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE, OR ANY WARRANTY OF NON-INFRINGEMENT OF ANY PATENT, TRADEMARK, OR OTHER INTELLECTUAL PROPERTY RIGHTS.
In case of dissatisfaction for a valid reason and claimed in writing by a purchaser within ninety (90) days of receipt of, PRODUCTS or SERVICES, JACKSON will, at its option, provide credit or replacement for the PRODUCT received or the SERVICES provided; JACKSON makes no other representations and this shall be the exclusive remedy of the purchaser. Please note specific policy for live mice.
Consistent with the requirement for a written understanding regarding animal care and use, the JACKSON Animal Care and Use Committee will review the animal care and use protocol(s) associated with any SERVICES to be performed at JACKSON, and JACKSON shall have ultimate responsibility and authority for the care of animals while on site or in JACKSON custody.
In no event shall JACKSON, its trustees, directors, officers, employees, and affiliates be liable for any causes of action or damages, including any direct, indirect, special, or consequential damages, arising out of the provision of MICE, PRODUCTS, or SERVICES, including economic damage or injury to property and lost profits, and including any damage arising from acts or negligence on the part of JACKSON, its agents or employees. Unless prohibited by law, in purchasing or receiving MICE, PRODUCTS, or SERVICES from JACKSON, purchaser or recipient, or any party claiming by or through them, expressly releases and discharges JACKSON from all such causes of action or damages, and further agrees to defend and indemnify JACKSON from any costs or damages arising out of any third party claims.
MICE, PRODUCTS or SERVICES are to be used in a safe manner and in accordance with all applicable governmental rules and regulations.
The foregoing represents the General Terms and Conditions applicable to JACKSON’s MICE, PRODUCTS or SERVICES. In addition, special terms and conditions of sale of certain MICE, PRODUCTS, or SERVICES may be set forth separately in JACKSON web pages, catalogs, price lists, contracts, and/or other documents, and these special terms and conditions shall also govern the sale of these MICE, PRODUCTS and SERVICES by JACKSON, and by its licensees and distributors.
Acceptance of delivery of MICE, PRODUCTS or SERVICES shall be deemed agreement to these terms and conditions. No purchase order or other document transmitted by purchaser or recipient that may modify the terms and conditions hereof, shall be in any way binding on JACKSON, and instead the terms and conditions set forth herein, including any special terms and conditions set forth separately, shall govern the sale of MICE, PRODUCTS or SERVICES by JACKSON.